Senior Director, Compound Development Team Lead, Multiple Myeloma
Senior Director, Compound Development Team Lead, Multiple Myeloma - 2406168891WDescriptionAt Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.The Compound Development Team Leader (CDTL) provides leadership to a cross-functional strategic compound development team and leads the development and execution of the compound strategy. Further, the CDTL champions the product/brand at all levels of J&J and is responsible for managing the alignment on communication on all CDT matters, as appropriate.Responsibilities:
Actively contributes to Compound Strategy decision-making by ensuring relevant research, analysis, and expertise is available.
Leads CDT in partnership with line functions to successfully develop the compound such that its value is maximized over its lifecycle while costs and time are minimized without sacrificing quality.
Builds team effectiveness, and leads the Compound Development Team (CDT) to achieve its goals through the networks of people/functions represented on the team. When necessary, negotiates with function heads on functional deliverables.
Challenges all functions on CDT to ensure that all issues and questions are being addressed, and that line function input into strategy and plans is adequate to meet the needs of the compound.
Leads the development and maintenance of the compound development strategy in collaboration with the Project Manager (PM).
Identifies potential issues and leads contingency planning; leads CDT problem solving and applies decision-making tools and techniques. Drives CDT to make effective and efficient decisions.
Leads resolution of conflict at the CDT, Oncology Senior Leadership Team (Oncology SLT), Development Committee (DC), Investment Committee (IC), Group Operating Committee (GOC) and joint steering committees for partnered compounds and senior management levels.
Ensures successful implementation of clinical supplies strategy.
Accountable for overall budget and project plan deliverables.
Acts as co-chair of global project teams with Alliance partners and aligns global strategy within a partnership, as applicable.
Major collaborator for the internal Alliance Managers for partnered compounds.
Ensures lessons learned at critical nodes in the development path.
Leads the communication of strategy, issues, and plans to the PMC, Oncology SLT, DC, IC, GOC, alliance partners, JPKK, regional management boards, and other key stakeholders.
Represents the interests of the compound/brand along with the global commercial lead at the Oncology SLT.
Builds and maintains team effectiveness and satisfaction.
Drives innovation by benchmarking
Works with functional management to:
Secure the required resources for project success
Influence optimal team composition
Align goals and objectives with CDT members
Coach and guide CDT members
Provide input for performance evaluation of CDT members
Goal: Align and implement on the Oncology SLT strategy.
QualificationsRequirements:
Candidate is preferred to hold a PhD, MD or M.D./Ph.D with minimum of 8-10 years, Masters with 10-12 years or equivalent experience in a leadership role as a part of a research-driven pharmaceutical company. Experience in leading clinical development programs in the appropriate TA is preferred.
Qualified candidates will have demonstrated a solid understanding of and involvement in the entire drug development process. He or she should have proven ability to work cross-functionally with interdisciplinary teams to access and optimize resources for development programs and experience working in a matrix organization. Candidate should be business orientated, having managed resources and budgets with proven record of leading projects trough successful transition from Discovery to Early Development and advancement of projects through preclinical and clinical development to Phase 2b within the therapeutic area. Excellent communication and leadership skills are a must, and a strong track record of producing results in a matrix-based environment is essential.
Domestic and international travel may be required of approximately 10 - 25% (depending on the compound type and stage of development).
This is a role that should be filled by a high performing individual in the organization who demonstrates outstanding leadership, influence, and communication skills.
Strong problem solving skills for developing creative solutions and meeting project objectives is required. Strong project planning and tracking skills. Demonstrated ability for strategic thinking and contingency planning.
Expert knowledge of the drug development process and familiarity with pharmaceutical portfolio risk management is required. Must understand requirements for successful commercialization of a new product.
Expert interpersonal skills for bridging between scientific and business participants, for negotiating timelines, resources and for effective international collaborations. Expert oral/written communication skills, allowing effective interactions with all levels of the organization. Expert critical and objectives interpretation of scientific and commercial information. Expert analytical skills for integrating and interpreting interdisciplinary project information.
High degree of organizational awareness and understanding of change management.
The anticipated base pay range for this position is $157,000 to $271,000.The anticipated base pay range for this position in the Bay area is $230,000 - $370,000.Johnson & Johnson is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability.ERADICATE CANCERPrimary Location NA-United StatesOther Locations NA-US-Pennsylvania-Spring HouseOrganization Janssen Research & Development, LLC (6084)Relocation Eligible: Yes - Within CountryTravel Yes, 25 % of the TimeJob Function Clinical Development & Research & Non-MDReq ID: 2406168891W